rs2285474

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002470.4(MYH3):​c.2952T>C​(p.Ser984Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.675 in 1,613,580 control chromosomes in the GnomAD database, including 379,800 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.57 ( 27804 hom., cov: 32)
Exomes 𝑓: 0.69 ( 351996 hom. )

Consequence

MYH3
NM_002470.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: -6.71

Publications

20 publications found
Variant links:
Genes affected
MYH3 (HGNC:7573): (myosin heavy chain 3) Myosin is a major contractile protein which converts chemical energy into mechanical energy through the hydrolysis of ATP. Myosin is a hexameric protein composed of a pair of myosin heavy chains (MYH) and two pairs of nonidentical light chains. This gene is a member of the MYH family and encodes a protein with an IQ domain and a myosin head-like domain. Mutations in this gene have been associated with two congenital contracture (arthrogryposis) syndromes, Freeman-Sheldon syndrome and Sheldon-Hall syndrome. [provided by RefSeq, Jul 2008]
MYHAS (HGNC:50609): (myosin heavy chain gene cluster antisense RNA) Predicted to enable primary miRNA binding activity. Predicted to be involved in response to muscle activity and skeletal muscle fiber development. Predicted to act upstream of or within with a positive effect on gene expression. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 17-10639448-A-G is Benign according to our data. Variant chr17-10639448-A-G is described in ClinVar as Benign. ClinVar VariationId is 129653.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.72 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.728 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH3NM_002470.4 linkc.2952T>C p.Ser984Ser synonymous_variant Exon 24 of 41 ENST00000583535.6 NP_002461.2
MYH3XM_011523870.4 linkc.2952T>C p.Ser984Ser synonymous_variant Exon 24 of 41 XP_011522172.1
MYH3XM_011523871.3 linkc.2952T>C p.Ser984Ser synonymous_variant Exon 24 of 41 XP_011522173.1
MYH3XM_047436127.1 linkc.2952T>C p.Ser984Ser synonymous_variant Exon 26 of 43 XP_047292083.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH3ENST00000583535.6 linkc.2952T>C p.Ser984Ser synonymous_variant Exon 24 of 41 5 NM_002470.4 ENSP00000464317.1
MYHASENST00000579914.2 linkn.705+25571A>G intron_variant Intron 4 of 4 4
MYHASENST00000584139.2 linkn.1041+25571A>G intron_variant Intron 7 of 8 3

Frequencies

GnomAD3 genomes
AF:
0.573
AC:
87028
AN:
151876
Hom.:
27798
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.295
Gnomad AMI
AF:
0.743
Gnomad AMR
AF:
0.561
Gnomad ASJ
AF:
0.703
Gnomad EAS
AF:
0.371
Gnomad SAS
AF:
0.523
Gnomad FIN
AF:
0.706
Gnomad MID
AF:
0.547
Gnomad NFE
AF:
0.734
Gnomad OTH
AF:
0.591
GnomAD2 exomes
AF:
0.610
AC:
153260
AN:
251126
AF XY:
0.622
show subpopulations
Gnomad AFR exome
AF:
0.294
Gnomad AMR exome
AF:
0.467
Gnomad ASJ exome
AF:
0.708
Gnomad EAS exome
AF:
0.362
Gnomad FIN exome
AF:
0.715
Gnomad NFE exome
AF:
0.728
Gnomad OTH exome
AF:
0.652
GnomAD4 exome
AF:
0.686
AC:
1002170
AN:
1461586
Hom.:
351996
Cov.:
71
AF XY:
0.684
AC XY:
497605
AN XY:
727094
show subpopulations
African (AFR)
AF:
0.277
AC:
9262
AN:
33474
American (AMR)
AF:
0.480
AC:
21452
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.705
AC:
18414
AN:
26136
East Asian (EAS)
AF:
0.368
AC:
14609
AN:
39698
South Asian (SAS)
AF:
0.540
AC:
46538
AN:
86248
European-Finnish (FIN)
AF:
0.720
AC:
38466
AN:
53418
Middle Eastern (MID)
AF:
0.556
AC:
3190
AN:
5736
European-Non Finnish (NFE)
AF:
0.729
AC:
810835
AN:
1111780
Other (OTH)
AF:
0.653
AC:
39404
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
18792
37583
56375
75166
93958
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19708
39416
59124
78832
98540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.573
AC:
87060
AN:
151994
Hom.:
27804
Cov.:
32
AF XY:
0.568
AC XY:
42165
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.295
AC:
12223
AN:
41462
American (AMR)
AF:
0.561
AC:
8558
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.703
AC:
2441
AN:
3472
East Asian (EAS)
AF:
0.372
AC:
1927
AN:
5178
South Asian (SAS)
AF:
0.523
AC:
2512
AN:
4804
European-Finnish (FIN)
AF:
0.706
AC:
7430
AN:
10530
Middle Eastern (MID)
AF:
0.544
AC:
160
AN:
294
European-Non Finnish (NFE)
AF:
0.734
AC:
49876
AN:
67968
Other (OTH)
AF:
0.595
AC:
1258
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1623
3246
4870
6493
8116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.680
Hom.:
54936
Bravo
AF:
0.547
Asia WGS
AF:
0.464
AC:
1620
AN:
3478
EpiCase
AF:
0.730
EpiControl
AF:
0.724

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 05, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Freeman-Sheldon syndrome Benign:2
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Arthrogryposis, distal, type 2B3 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Contractures, pterygia, and variable skeletal fusions syndrome 1B Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Distal arthrogryposis type 2B1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
0.0030
DANN
Benign
0.22
PhyloP100
-6.7
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2285474; hg19: chr17-10542765; COSMIC: COSV56862416; API